The acute phase proteins c-CRP and HPT and the serum marker 25(OH)D were not significantly different among the groups of dogs with nasal cavity disease in the present study and are, therefore, not clinically useful for the reliable detection of nasal cavity disease and consequently not for therapy monitoring. This evidence concerns the gene MRS2 and nasal cavity disorder.